Danish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Health Burden of Hypophosphatasia

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
Linket gemmes på udklipsholderen
StatusAfsluttet
Sponsorer
Sheffield Teaching Hospitals NHS Foundation Trust

Nøgleord

Abstrakt

Hypophosphatasia (HPP) is a genetic disorder caused by mutation in the tissue-non-specific alkaline phosphatase gene (TNSALP). It causes impaired bone mineralisation, fractures, tooth loss, muscle weakness and possibly other adverse health outcomes.
The infantile-onset forms are severe, and were often fatal until the recent availability of a treatment (Asfotase Alfa). The childhood-onset forms are less severe, and the adult-onset form is mild, and often unrecognised or misdiagnosed as osteoporosis.
The less severe forms of the disease are not well described, and because there has been no available treatment there has not been much research in adults. However, now that treatment is available there is a possibility of a clinical trial in adults. To know whether there is a need for a trial there is a need to determine if there is a significant personal and economic burden associated with the less severe forms of HPP.
The study consists of a clinical interview and notes review of adults and children with confirmed (by biochemical and genetic testing) HPP attending metabolic bone clinics in Sheffield to establish their clinical problems and healthcare use. There are currently about 26 adults and 8 children attending clinics in Sheffield.
The information will be used to plan a data search and health economic analysis of the burden of HPP from the UK Clinical Practice Research Database in collaboration with Pharmatelligence (a healthcare data group based within the University of Cardiff).

Beskrivelse

This is an observational retrospective study to describe the clinical problems and healthcare use of adults and children with hypophosphatasia.

Interviews will be conducted with patients with childhood- and adult-onset hypophosphatasia (and the parents of the children). Hospital notes, appointment records and GP summary care records will also be reviewed.

These sources will be used to describe their clinical problems, how these problems affect their daily function, and which healthcare services they have used.

Patients will attend for a single visit to obtain informed consent and conduct the interview.

Health problems specifically assessed in detail will include:

- Fractures

- Dental problems

- Skeletal complications

- Mobility problems

- Neurosurgical complications

- Seizures

- Respiratory complications

- Depression and anxiety

- Side effects of treatment including hypercalcaemia and hyperphosphataemia Deaths will also be recorded

Health care resource assessment will include

- Primary care episodes

- Secondary and tertiary care outpatient episodes

- In-patient episodes

- Nutritional support

- Therapy support

- Dental treatment

- Over the counter medication use

A case data report form will be developed as an iterative process through the period of the interviews to ensure that all data of potential interest is captured. Because the condition is not well described it is important that the data reported is not limited to the areas where it might be already expected to find problems.

Datoer

Sidst bekræftet: 01/31/2019
Først indsendt: 03/31/2016
Anslået tilmelding indsendt: 04/20/2016
Først indsendt: 04/25/2016
Sidste opdatering indsendt: 02/11/2019
Sidste opdatering indsendt: 02/14/2019
Faktisk startdato for undersøgelsen: 10/31/2016
Anslået primær afslutningsdato: 11/30/2017
Anslået afslutningsdato for undersøgelsen: 11/30/2017

Tilstand eller sygdom

Hypophosphatasia

Intervention / behandling

Other: Adults and children with hypophosphatasia

Fase

-

Armgrupper

ArmIntervention / behandling
Adults and children with hypophosphatasia
Healthcare use interview
Other: Adults and children with hypophosphatasia

Kriterier for støtteberettigelse

Køn, der er berettiget til undersøgelseAll
PrøveudtagningsmetodeNon-Probability Sample
Accepterer sunde frivilligeJa
Kriterier

Inclusion Criteria:

- Hypophosphatasia

Exclusion Criteria:

- Unable/unwilling to give informed consent

Resultat

Primære resultatforanstaltninger

1. description of healthcare use [one day study visit]

Descriptive data on which health care services the patient has used in relation to HPP

Sekundære resultatforanstaltninger

1. healthcare use appointments [one day study visit]

descriptive data on number of healthcare encounters

2. healthcare cost [one day study visit]

estimated healthcare cost attributable to HPP

Deltag i vores
facebook-side

Den mest komplette database med medicinske urter understøttet af videnskab

  • Arbejder på 55 sprog
  • Urtekurer, der understøttes af videnskab
  • Urtegenkendelse ved billede
  • Interaktivt GPS-kort - tag urter på stedet (kommer snart)
  • Læs videnskabelige publikationer relateret til din søgning
  • Søg medicinske urter efter deres virkninger
  • Organiser dine interesser og hold dig opdateret med nyhedsundersøgelser, kliniske forsøg og patenter

Skriv et symptom eller en sygdom, og læs om urter, der kan hjælpe, skriv en urt og se sygdomme og symptomer, den bruges mod.
* Al information er baseret på offentliggjort videnskabelig forskning

Google Play badgeApp Store badge